Skip to main content
SpringerLink
Log in

Hypertones Kochsalz

Therapie der Lungenerkrankungen bei Mukoviszidose – Mechanismen und Langzeitwirkung

  • Pädiatrie aktuell
  • Published:
Monatsschrift Kinderheilkunde Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Donaldson SH, Bennett WD, Zeman KL, Knowles MR, Tarran R, Boucher RC (2006) Mucus clearance and lung function in cystic fibrosis with hypertonic saline. N Engl J Med 354: 241–250

    Article  PubMed  Google Scholar 

  2. Elkins MR, Robinson M, Rose BR, Harbour C, Moriarty CP, Marks GB, Belousova EG, Xuan W, Bye PT (2006) A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. N Engl J Med 354: 229–240

    Article  PubMed  Google Scholar 

  3. Matsui H, Grubb BR, Tarran R, Randell SH, Gatzy JT, Davis CW, Boucher RC (1998) Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell 95: 1005–1015

    Article  PubMed  Google Scholar 

  4. Mall M, Grubb BR, Harkema JR, O’Neal WK, Boucher RC (2004) Increased airway epithelial Na(+) absorption produces cystic fibrosis-like lung disease in mice. Nat Med 10: 487–493

    Article  PubMed  Google Scholar 

  5. Ratjen F (2006) Restoring airway surface liquid in cystic fibrosis. N Engl J Med 354: 291–293

    Article  PubMed  Google Scholar 

  6. Fuchs HJ, Borowitz DS, Christiansen DH, Morris EM, Nash ML, Ramsey BW, Rosenstein BJ, Smith AL, Wohl ME (1994) Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. N Engl J Med 331: 637–642

    Article  PubMed  Google Scholar 

  7. Suri R, Metcalfe C, Lees B, Grieve R, Flather M, Normand C, Thompson S, Bush A, Wallis C (2001) Comparison of hypertonic saline and alternate-day or daily recombinant human deoxyribonuclease in children with cystic fibrosis: a randomised trial. Lancet 358: 1316–1321

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt

Es besteht kein Interessenkonflikt. Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen. Die Präsentation des Themas ist unabhängig und die Darstellung der Inhalte produktneutral.

Author information

Authors and Affiliations

  1. Universitätsklinik für Kinder- und Jugendmedizin, Kinderheilkunde III, Pädiatrische Pneumologie und Mukoviszidose-Zentrum, Im Neuenheimer Feld 153, 69120, Heidelberg

    M. Mall

Authors
  1. M. Mall
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Mall.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mall, M. Hypertones Kochsalz. Monatsschr Kinderheilkd 154, 907–909 (2006). https://doi.org/10.1007/s00112-006-1404-6

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00112-006-1404-6

Search

Navigation